Premature infants given the probiotic Lactobacillus reuteri did not have lower rates of infection or mortality compared with babies given a placebo, researchers from Wake Forest School of Medicine reported. However, Dr. Frank Greer noted that the study in Pediatrics did not include data on whether the infants, who were treated in a hospital neonatal ICU, were also given antibiotics, which he said could have affected the efficacy of the probiotics.

Related Summaries